What question did this study set out to answer?

The research aims to investigate how microbiomes and sex differences affect drug metabolism and treatment outcomes.

April 17, 2026

Clinically significant interactions between drugs, microbiome, and sex

Key Points

The research aims to investigate how microbiomes and sex differences affect drug metabolism and treatment outcomes.
Conduct population pharmacokinetic studies with microbiome composition and sex as covariates.
Perform clinical studies focusing on treatment outcomes related to microbiome interactions.
Identified gaps in current understanding of microbiome effects on drug metabolism.
Highlighted the lack of data on how sex influences these interactions.

Abstract

Current knowledge about the clinically significant effects of microbiomes on drug metabolism and treatment outcomes in humans is very scarce, while the question of sex differences remains unanswered. Both population pharmacokinetic studies, including microbiome composition and sex as covariates, and clinical studies of treatment outcomes will be necessary to fill this knowledge gap.

Bookmark

Clinically significant interactions between drugs, microbiome, and sex

Key Points

Abstract

Cite This Study

Also Consider

Also Consider